Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Ltd Share Price Today: Live Updates & Key Insights

Get insights on Sotac Pharmaceuticals Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Sotac Pharmaceuticals Ltd Share Price Chart

Sotac Pharmaceuticals Ltd Fundamentals

Traded Volume: 1,200

Market Cap(Cr): 143

Avg Traded Price 125.88

1 Year return 4.45%

Upper Circuit 129

Lower Circuit 129

P/E TTM 18.00

P/B Ratio 7.00

Traded Value(Cr) 1.55

EPS TTM 7.264

Book value 7.264

Dividend 0.00%

Sotac Pharmaceuticals Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Sotac Pharmaceuticals Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Sotac Pharmaceuticals Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W +0.39%

1M +19.33%

3M +3.20%

1Y +4.45%

YTD +17.19%

Sotac Pharmaceuticals Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Sotac Pharmaceuticals Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 3600.00

Day Before Yesterday 1200.00

1W Avg null

1M Avg 2640.00

3M Avg 4567.74

Sotac Pharmaceuticals Ltd Technical Details

Sotac Pharmaceuticals Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 129

Support 2 129

Support 3 129

Pivot Point : 129

Resistance 1 129

Resistance 2 129

Resistance 3 129

Sotac Pharmaceuticals Ltd Corporate Actions

Sotac Pharmaceuticals Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Sotac Pharmaceuticals Ltd’s capital allocation strategies.

All

Ex-Date 19-Sep-2025 Type D Description 0.10/share@1.00% Record Date 19-Sep-2025 Ratio 1.00

Dividends

Announcement Date 19-Sep-2025 Ex Dividend Date 19-Sep-2025 Dividend(%) 1

Bonus

No Bonus has been declared by SOTAC

Splits

No Split has been declared by SOTAC

Others

Rights No Rights has been declared by SOTAC

Sotac Pharmaceuticals Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Sotac Pharmaceuticals Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Sotac Pharmaceuticals Ltd's relative performance and valuation against major competitors.

Stock Name Parnax Lab Ltd ₹128.00 (+0.23%) M. Cap (Cr) 1.47 1 Yr Return (%) -28.89% P/E (TTM) 13.60 PB Ratio 1.86

Stock Name Smruthi Organics Ltd ₹127.00 (-1.74%) M. Cap (Cr) 1.45 1 Yr Return (%) -6.38% P/E (TTM) 42.88 PB Ratio 2.03

Stock Name Quest Laboratories Ltd ₹88.00 (+2.27%) M. Cap (Cr) 1.44 1 Yr Return (%) NaN% P/E (TTM) 10.63 PB Ratio 4.36

Stock Name Sotac Pharmaceuticals Ltd ₹129.00 (-0.65%) M. Cap (Cr) 1.43 1 Yr Return (%) +4.45% P/E (TTM) 17.76 PB Ratio 3.02

Stock Name Lactose (India) Ltd ₹110.65 (-2.21%) M. Cap (Cr) 1.39 1 Yr Return (%) -37.18% P/E (TTM) 31.11 PB Ratio 2.62

Stock Name Achyut Healthcare Ltd ₹5.60 (+1.45%) M. Cap (Cr) 1.32 1 Yr Return (%) +15.23% P/E (TTM) 234.41 PB Ratio 4.17

Stock Name Bal Pharma Ltd ₹81.86 (+1.87%) M. Cap (Cr) 1.30 1 Yr Return (%) -34.88% P/E (TTM) 18.21 PB Ratio 1.68

Sotac Pharmaceuticals Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Sotac Pharmaceuticals Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 -6.08 Mar 2024 -19.79 Mar 2023 8.54 Mar 2022 6.35 Mar 2021 2.35

PARTICULARS Investing Activities Mar 2025 -1.89 Mar 2024 -12.53 Mar 2023 -10.93 Mar 2022 -3.52 Mar 2021 -1.20

PARTICULARS Financing Activities Mar 2025 7.78 Mar 2024 23.36 Mar 2023 11.97 Mar 2022 -2.83 Mar 2021 -1.17

PARTICULARS Net Cash Flow Mar 2025 -0.20 Mar 2024 -8.96 Mar 2023 9.57 Mar 2022 0.00 Mar 2021 -0.02

Sotac Pharmaceuticals Ltd Shareholding Pattern

This shows the ownership breakdown of Sotac Pharmaceuticals Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 72.85%

Public 11.01%

Other Institutions 0.0%

FII 16.14%

Mutual Funds null%

About Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name of M/s Sotac Pharmaceuticals, pursuant to a Deed of Partnership dated October 28, 2015. Thereafter M/s. Sotac Pharmaceuticals was converted from Partnership Firm to a Private Limited Company in the name of Sotac Pharmaceuticals Private Limited dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat. Later on, Company converted into a Public Limited Company and the name of Company was changed to Sotac Pharmaceuticals Limited' dated November 22, 2022 issued by Registrar of Companies, Ahmedabad.The Company is a part of SOTAC Group, based at Gujarat and is engaged in manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis. The Company is pharma manufacturer, specializing in manufacturing of a wide range of pharmaceutical products such as Non Beta-Lactam (general) tablets, beta-lactam coated tablets, beta-lactam uncoated tablets, Non Beta-Lactam (general) capsules, beta-lactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray and cream. The Company's therapeutic portfolio include Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Iron, Anti-Cold, AntiAllergic, Derma Products, Antacid, Anti-Ulcerants, PPI, Anti-Emetics, Cardiac, Anti-Hypertensives, Analgesic, AntiPyretic, Anti-Inflammatory, Anti-Bacterial, Anti-Viral, General Antibiotics IP-Lactams & Non-IP-Lactams, Anti-Fungal, Cephalosporin. Consequently, as a Group, it cater to a wide spectrum of companies for formulation development, clinical batch production, commercial scale productions.The Company commenced manufacturing facility in year 2017, which had an installed capacity to manufacture 90 Crore tables / year, 14 Crore Capsules / year. Later, in 2022, the Company acquired 71% holding in SOTAC Healthcare Private Limited and 100% holding in SOTAC Research Private Limited, thus making them as wholly owned Subsidiary Companies in April, 2022. Thereafter, it started a new venture, SOTAC Lifescience Private Limited and held 51% of total paid-up capital in it. In April 2023, Company made an IPO of 3000000 fresh issue of Equity Shares of face value of Rs 10 each by raising funds aggregating to Rs 33 Crore.

Chairman & Managing Director

Sharadkumar Dashrathbhai Patel

Registered office Plot No PF-21 Nr ACME Pharma, Opp Teva Pharma Sanand GIDC-II, Ahmedabad, Gujarat, 382110

FAX :91-90819 93300

Background

Incorporation Year 2015

Face Value ₹10.00

Market Lot 0

Sotac Pharmaceuticals Ltd Latest News

VIEW MORE NEWS

FAQs on Sotac Pharmaceuticals Ltd